Repeat stereotactic body radiotherapy for oligometastatic disease

被引：0
|
作者：
Adilovic, S. [1 ]
Willmann, J. [2 ]
Badra, E. Vlaskou [1 ]
Christ, S. M. [1 ]
Ahmadsei, M. [1 ]
Tanadini-Lang, S. [1 ]
Mayinger, M. [1 ]
Guckenberger, M. [1 ]
Andratschke, N. [1 ]
机构：
[1] Univ Zurich Hosp, Dept Radiat Oncol, Zurich, Switzerland
[2] Paul Scherrer Inst, Ctr Proton Therapy, Villigen, Switzerland
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD-0070
引用
收藏
页码：S37 / S38
页数：2
相关论文
共 50 条
  • [41] Stereotactic ablative radiotherapy for oligometastatic disease: why and how?
    Widder, J.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S246 - S247
  • [42] Stereotactic Body Radiotherapy in bone oligometastatic prostate cancer patients
    Trippa, F.
    Arcidiacono, F.
    Di Marzo, A.
    Draghini, L.
    Anselmo, P.
    Terenzi, S.
    Casale, M.
    Fabiani, S.
    Maranzano, E.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S850 - S851
  • [43] Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
    Decaestecker, Karel
    De Meerleer, Gert
    Lambert, Bieke
    Delrue, Louke
    Fonteyne, Valerie
    Claeys, Tom
    De Vos, Filip
    Huysse, Wouter
    Hautekiet, Arne
    Maes, Gaethan
    Ost, Piet
    RADIATION ONCOLOGY, 2014, 9
  • [44] Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
    Karel Decaestecker
    Gert De Meerleer
    Bieke Lambert
    Louke Delrue
    Valérie Fonteyne
    Tom Claeys
    Filip De Vos
    Wouter Huysse
    Arne Hautekiet
    Gaethan Maes
    Piet Ost
    Radiation Oncology, 9
  • [45] Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma
    Ranck, Mark C.
    Golden, Daniel W.
    Corbin, Kimberly S.
    Hasselle, Michael D.
    Liauw, Stanley L.
    Stadler, Walter M.
    Hahn, Olwen M.
    Weichselbaum, Ralph R.
    Salama, Joseph Kamel
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (06): : 589 - 595
  • [46] Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer
    Gkika, E.
    Adebahr, S.
    Kirste, S.
    Schimek-Jasch, T.
    Wiehle, R.
    Claus, R.
    Wittel, U.
    Nestle, U.
    Baltas, D.
    Grosu, A. L.
    Brunner, T. B.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (06) : 433 - 443
  • [47] Stereotactic body radiotherapy (SBRT) for oligometastatic prostate cancer patients
    Kalinauskaite, G.
    Stromberger, C.
    Tinhofer, I
    Kufeld, M.
    Senger, C.
    Budach, V
    Gruen, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S153 - S154
  • [48] Stereotactic body radiotherapy for adrenal metastases of oligometastatic or oligoprogressive tumors
    Koenig, L.
    Haefner, M. F.
    Katayama, S.
    Koerber, S. A.
    Tonndorf-Martini, E.
    Bernhardt, D.
    Von Nettelbladt, B.
    Weykamp, F.
    Hoegen, P.
    Klueter, S.
    Susko, M. S.
    Debus, J.
    Hoerner-Rieber, J.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S563 - S563
  • [49] Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
    Weykamp, Fabian
    Koenig, Laila
    Seidensaal, Katharina
    Forster, Tobias
    Hoegen, Philipp
    Akbaba, Sati
    Mende, Stephan
    Welte, Stefan E.
    Deutsch, Thomas M.
    Schneeweiss, Andreas
    Debus, Juergen
    Hoerner-Rieber, Juliane
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [50] Utilization of stereotactic ablative radiotherapy in the management of oligometastatic disease
    Broomfield, J. A.
    Greenspoon, J. N.
    Swaminath, A.
    CURRENT ONCOLOGY, 2014, 21 (03) : 115 - 117
12345